In ophthalmology, Zhuhai Sunny Medical Device Co., Ltd. and Guangzhou Youvision® Biotechnology Co. Ltd. rely on platform and resources, focusing on cataract surgery, devoting itself to eliminate blindness in China, and builds bridges between products and doctors. Currently，the products on the market include AAREN® intraocular lens、HexaVision® intraocular lens、Youvision® corea graft.
AAREN intraocular lens has two core technology patents: (1) Impurity dissolution technology, for hydrophilic acrylic materials, the application of molecular purification patents, through the unique formula of solvent extraction repeatedly, the impurities adsorbed in the material are thoroughly removed to ensure long-term visual clarity after cataract surgery; (2) Aspheric tolerance bias technology: the application of bi-directional design patents. In the front and back surface of the crystal, the central edge is cut uniquely, and spherical aberration and chromatic aberration are corrected simultaneously, which realizes real visual comfort in the case of weak light and crystal offset. At the same time, the use of two core technologies makes the product performance better and becomes the most trusted choice for ophthalmologists.
HexaVision, France, has been focusing on intraocular lenses for 30 years, and has always been focusing on the practice and application of heparin technology to provide strong support for higher quality cataract surgery. The most common application of heparin surface treatment technology is to reduce inflammation, prevent the reoccurrence of cataract, suitable for diabetic patients.
Youvision® corea graft uses blindness and recovery as the main therapeutic index. It has been reported by CCTV news broadcasting, Guangdong Satellite TV and major mainstream media for many times.